Location History:
- Shizuoka, JP (2002 - 2011)
- Fujieda, JP (2011)
Company Filing History:
Years Active: 2002-2011
Title: Shunsuke Watanabe: Innovator in Pharmaceutical Composition
Introduction
Shunsuke Watanabe is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the absorption of biologically active peptides. With a total of 16 patents to his name, Watanabe's work is recognized for its innovative approach to improving drug delivery systems.
Latest Patents
Watanabe's latest patents focus on pharmaceutical compositions for oral use that demonstrate improved absorption. One notable invention involves an agent designed to inhibit the decomposition of biologically active peptides by digestive enzymes. This agent utilizes aminoalkyl methacrylate copolymer E as an effective ingredient. The invention also includes methods for reducing the viscosity of the gastrointestinal mucosa and enhancing the permeability of biologically active peptides. Another significant patent presents a pharmaceutical composition that combines a drug, aminoalkyl methacrylate copolymer E, and an acidic substance, which collectively improve oral absorption.
Career Highlights
Throughout his career, Shunsuke Watanabe has worked with notable companies such as Off Corporation Inc. and Yamanouchi Pharmaceutical Company Ltd. His expertise in pharmaceutical sciences has led to advancements that benefit drug formulation and delivery.
Collaborations
Watanabe has collaborated with esteemed colleagues, including Kazuhiro Sako and Toyohiro Sawada. These partnerships have contributed to the successful development of his innovative pharmaceutical compositions.
Conclusion
Shunsuke Watanabe's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in enhancing drug absorption. His work continues to influence the development of effective pharmaceutical solutions.